Overview
Stacy Nerenstone is an Oncologist in Hartford, Connecticut. Dr. Nerenstone is rated as an Experienced provider by MediFind in the treatment of Wilms Tumor. Her top areas of expertise are Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Breast Cancer, and Paget Disease of the Breast.
Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Yale University
Michael Hurwitz is an Oncologist in New Haven, Connecticut. Dr. Hurwitz is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Adult Soft Tissue Sarcoma, and Orchiectomy.
Hartford Hospital
Jeffrey Kamradt is a Hematologist Oncology specialist and an Oncologist in Hartford, Connecticut. Dr. Kamradt is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes.
Yale University
David Braun is an Oncologist in New Haven, Connecticut. Dr. Braun is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Wilms Tumor.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Nerenstone isDistinguished. Learn about Breast Cancer.
- Ovarian CarcinosarcomaDr. Nerenstone isDistinguished. Learn about Ovarian Carcinosarcoma.
- Paget Disease of the BreastDr. Nerenstone isDistinguished. Learn about Paget Disease of the Breast.
- Virilizing Ovarian TumorDr. Nerenstone isDistinguished. Learn about Virilizing Ovarian Tumor.
- Advanced
- AngiosarcomaDr. Nerenstone isAdvanced. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Nerenstone isAdvanced. Learn about Inflammatory Breast Cancer.
- Malignant Mixed Mullerian TumorDr. Nerenstone isAdvanced. Learn about Malignant Mixed Mullerian Tumor.
- Ovarian CancerDr. Nerenstone isAdvanced. Learn about Ovarian Cancer.
- Sertoli-Leydig Cell TumorDr. Nerenstone isAdvanced. Learn about Sertoli-Leydig Cell Tumor.
- Testicular Yolk Sac TumorDr. Nerenstone isAdvanced. Learn about Testicular Yolk Sac Tumor.
- Experienced
- Adult Soft Tissue SarcomaDr. Nerenstone isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Breast Cancer in MenDr. Nerenstone isExperienced. Learn about Breast Cancer in Men.
- Cervical CancerDr. Nerenstone isExperienced. Learn about Cervical Cancer.
- Chromophobe Renal Cell CarcinomaDr. Nerenstone isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Nerenstone isExperienced. Learn about Clear Cell Sarcoma.
- Colorectal CancerDr. Nerenstone isExperienced. Learn about Colorectal Cancer.